Two Shares Face To Face: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), CDW Corporation (NASDAQ:CDW)

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) closed at $2.64 on the last trading session with an decrease of -4%, whereas, it previously closed at $2.75. The company has a market capitalization of $233.8 Million. The company traded shares of 757852 on the trading day while its three month average volume stands at 1.85 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) produced diluted EPS of -0.98. The EPS estimate for next year as estimated by analysts is at -0.67 while EPS for next quarter is estimated at -0.21. Earnings per Share growth for this year is reported at -11.9, while the analysts estimated the EPS growth for next year at -0.67% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -3.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stands at 0 and Price to Book or P/B for the most recent quarter stands at 4.06. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) are reported at 4.8 and 4.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stands at -78.9, -94.5 and 0 respectively

The trailing twelve month Revenue of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is reported at 0 with income of -48800000. The outstanding shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) are 88.56 Million. The institutional Ownership of the shares of 68.5 stands at 0.80%, this figure is increased 65.33 in the last six months. The insider ownership for the shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is ticked at 0.1%, the figure is rose 110.23% in the last six months.

Some other important financial aspects to be discussed here for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is the Mean Target Price estimated by the analysts which stands at 5.38. The 52 week high of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is placed at 5.40 and 52 week low is standing at 0.77.

Performance wise the shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) rose up 3.13% for the week, it also rise 25.71% for the monthly performance, while for the quarter it went down 123.73%. The shares increase 69.23% for the half year and flew up for the Year-To-Date performance. The shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shrinked -31.43% for the yearly performance.

CDW Corporation (NASDAQ:CDW)

CDW Corporation (NASDAQ:CDW) closed at $113.81 on the last trading session with an decrease of -4.51%, whereas, it previously closed at $119.19. The company has a market capitalization of $16.62 Billion. The company traded shares of 1.62 Million on the trading day while its three month average volume stands at 1.14 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of CDW Corporation (NASDAQ:CDW) produced diluted EPS of 4.99. The EPS estimate for next year as estimated by analysts is at 7.34 while EPS for next quarter is estimated at 1.37. Earnings per Share growth for this year is reported at 47.5, while the analysts estimated the EPS growth for next year at 7.34% and Earnings growth for next 5 years stands at 11.88% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 37.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of CDW Corporation (NASDAQ:CDW) is at 22.82 while the forward p/e is at 15.51. The P/S or Price to Sales ratio of CDW Corporation (NASDAQ:CDW) stands at 0.92 and Price to Book or P/B for the most recent quarter stands at 17.59. The Price to Free Cash Flow ratio or P/FCF is reported at 22.77. The quick ratio and the current ratio of CDW Corporation (NASDAQ:CDW) are reported at 1.1 and 1.3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for CDW Corporation (NASDAQ:CDW) stands at 9.1, 73.4 and 18.8 respectively

The trailing twelve month Revenue of CDW Corporation (NASDAQ:CDW) is reported at 18.03 Billion with income of 736.8 Million. The outstanding shares of CDW Corporation (NASDAQ:CDW) are 146.02 Million. The institutional Ownership of the shares of 95.7 stands at 0.80%, this figure is decreased -2.57 in the last six months. The insider ownership for the shares of CDW Corporation (NASDAQ:CDW) is ticked at 0.9%, the figure is plummeted -16.26% in the last six months.

Some other important financial aspects to be discussed here for CDW Corporation (NASDAQ:CDW) is the Mean Target Price estimated by the analysts which stands at 141.5. The 52 week high of CDW Corporation (NASDAQ:CDW) is placed at 146.09 and 52 week low is standing at 90.53.

Performance wise the shares of CDW Corporation (NASDAQ:CDW) fell down -1.96% for the week, it also fell -16.41% for the monthly performance, while for the quarter it went up -14.52%. The shares decrease -3.6% for the half year and plummeted for the Year-To-Date performance. The shares of CDW Corporation (NASDAQ:CDW) grew 22.1% for the yearly performance.